These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 7351056

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients.
    Franciosa JA, Pierpont G, Cohn JN.
    Ann Intern Med; 1977 Apr; 86(4):388-93. PubMed ID: 848799
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Oral hydralazine in chronic heart failure: sustained beneficial hemodynamic effects.
    Chatterjee K, Ports TA, Brundage BH, Massie B, Holly AN, Parmley WW.
    Ann Intern Med; 1980 May; 92(5):600-4. PubMed ID: 7386999
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Differential hemodynamic and sympathoadrenal effects of sodium nitroprusside and hydralazine in hypertensive subjects.
    Shepherd AM, Irvine NA.
    J Cardiovasc Pharmacol; 1986 May; 8(3):527-33. PubMed ID: 2425168
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Vasodilator therapy with a new stable prostacyclin analog, OP-41483, for congestive heart failure due to coronary artery disease and comparison of hemodynamic effects and platelet aggregation with nitroprusside.
    Yui Y, Takatsu Y, Hattori R, Susawa T, Sakaguchi K, Yui N, Kawai C.
    Am J Cardiol; 1986 Nov 01; 58(10):1042-5. PubMed ID: 3535472
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Precipitation of heart failure following sudden withdrawal of hydralazine.
    Black JR, Mehta J.
    Chest; 1979 Jun 01; 75(6):724-5. PubMed ID: 436528
    [Abstract] [Full Text] [Related]

  • 16. Hemodynamic effects of vasodilators on pulmonary hypertension in decompensated chronic obstructive pulmonary disease.
    Cerdá E, Esteban A, de la Cal MA, Fernández A, García A.
    Crit Care Med; 1985 Apr 01; 13(4):221-3. PubMed ID: 3979067
    [Abstract] [Full Text] [Related]

  • 17. Assessment of vasodilator therapy in patients with severe congestive heart failure: limitations of measurements of left ventricular ejection fraction and volumes.
    Firth BG, Dehmer GJ, Markham RV, Willerson JT, Hillis LD.
    Am J Cardiol; 1982 Nov 01; 50(5):954-9. PubMed ID: 6291370
    [Abstract] [Full Text] [Related]

  • 18. Hemodynamic and neurochemical determinates of renal function in chronic heart failure.
    Gilbert C, Cherney DZ, Parker AB, Mak S, Floras JS, Al-Hesayen A, Parker JD.
    Am J Physiol Regul Integr Comp Physiol; 2016 Jan 15; 310(2):R167-75. PubMed ID: 26561645
    [Abstract] [Full Text] [Related]

  • 19. Hemodynamic advantage of combined administration of oral ibopamine and nitroprusside in patients with ischemic and idiopathic congestive cardiomyopathy.
    Dei Cas L, Fappani A, Riva S, Metra M, Cicogna R, Manca C, Visioli O.
    Clin Cardiol; 1985 Aug 15; 8(8):427-32. PubMed ID: 4028536
    [Abstract] [Full Text] [Related]

  • 20. Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose.
    Magorien RD, Triffon DW, Desch CE, Bay WH, Unverferth DV, Leier CV.
    Ann Intern Med; 1981 Jul 15; 95(1):5-13. PubMed ID: 7247126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.